NCX 701

Known as: NCX-701, NCX701 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2013
01220002013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The Na⁺/Ca²⁺ exchanger (NCX) is thought to play an important role in the pathogenesis of pentylenetetrazole (PTZ)-induced tonic… (More)
Is this relevant?
2011
2011
The α₂-adrenergic system is involved in pain processing and inflammation-induced sensitization. α₂-adrenoceptor agonists induce… (More)
Is this relevant?
2009
2009
BACKGROUND AND PURPOSE Neuropathic pain is characterized by a poor response to classic analgesics. In the present study, we have… (More)
Is this relevant?
Review
2007
Review
2007
The combination of numerous classic drugs with nitric oxide donors has led to the development of new compounds with promising… (More)
Is this relevant?
2005
2005
We have reported that subanalgesic doses of new generation non-steroidal anti-inflammatory drugs (NSAIDs) enhance the… (More)
Is this relevant?
2005
2005
Subanalgesic doses of the non-steroidal antiinflammatory drugs (NSAID) dexketoprofen trometamol and nitroparacetamol (NCX-701… (More)
Is this relevant?
2003
2003
Nitric oxide (NO)-releasing NSAIDs have been shown to be safer and more potent as antinociceptive and anti-inflammatory agents… (More)
Is this relevant?
2002
2002
1. Non-steroidal anti-inflammatory drugs (NSAIDs) are effective anti-inflammatory and analgesic drugs although they also induce… (More)
Is this relevant?
2002
2002
NCX-701 is a nitric oxide (NO)-releasing acetaminophen (APAP) derivative. In the present study we demonstrated that NCX-701 is as… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2000
2000
Nitroparacetamol (NCX-701) is a newly synthesized nitric oxide-releasing derivative of paracetamol. Following i.p. administration… (More)
Is this relevant?